Fintel reports that on October 10, 2024, Barclays upgraded their outlook for CVS Health (NYSE:CVS) from Equal-Weight to Overweight.
Analyst Price Forecast Suggests 2.43% Downside
As of September 25, 2024, the average one-year price target for CVS Health is $65.23/share. The forecasts range from a low of $59.59 to a high of $80.85. The average price target represents a decrease of 2.43% from its latest reported closing price of $66.85 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for CVS Health is 323,836MM, a decrease of 10.51%. The projected annual non-GAAP EPS is 9.71.
What is the Fund Sentiment?
There are 3,172 funds or institutions reporting positions in CVS Health. This is an decrease of 289 owner(s) or 8.35% in the last quarter. Average portfolio weight of all funds dedicated to CVS is 0.37%, an increase of 15.04%. Total shares owned by institutions increased in the last three months by 6.25% to 1,280,619K shares. 
The put/call ratio of CVS is 0.66, indicating a bullish outlook.
What are Other Shareholders Doing?
Dodge & Cox holds 61,683K shares representing 4.90% ownership of the company. In its prior filing, the firm reported owning 41,013K shares , representing an increase of 33.51%. The firm increased its portfolio allocation in CVS by 15.22% over the last quarter.
Capital World Investors holds 56,024K shares representing 4.45% ownership of the company. In its prior filing, the firm reported owning 43,777K shares , representing an increase of 21.86%. The firm decreased its portfolio allocation in CVS by 6.64% over the last quarter.
DODGX - Dodge & Cox Stock Fund holds 41,232K shares representing 3.28% ownership of the company. In its prior filing, the firm reported owning 27,544K shares , representing an increase of 33.20%. The firm increased its portfolio allocation in CVS by 11.43% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 39,661K shares representing 3.15% ownership of the company. In its prior filing, the firm reported owning 39,567K shares , representing an increase of 0.24%. The firm decreased its portfolio allocation in CVS by 27.82% over the last quarter.
Capital Research Global Investors holds 35,456K shares representing 2.82% ownership of the company. In its prior filing, the firm reported owning 13,144K shares , representing an increase of 62.93%. The firm increased its portfolio allocation in CVS by 93.71% over the last quarter.
CVS Health Background Information
(This description is provided by the company.)
CVS Health is a different kind of health care company. It is a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, it is meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, its diversified model engages one in three Americans each year. From its innovative new services at HealthHUB locations, to transformative programs that help manage chronic conditions, it is making health care more accessible, more affordable and simply better.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
